Fate Therapeutics (FATE) EBITDA (2012 - 2026)
Fate Therapeutics' EBITDA came in at -$28.35 million for Q2 2026, compared with -$33.69 million a year earlier.
Powered by 
Analysis
Fate Therapeutics (FATE) EBITDA (2012 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Fate Therapeutics reported EBITDA of -$121.6 million; for FY2025, it was -$134.8 million.
- Going back by year, EBITDA was -$191.28 million in FY2024, -$165.02 million in FY2023, -$291.91 million in FY2022 and -$207.1 million in FY2021.
- The Q2 2026 figure represents the highest quarterly EBITDA since Q1 2023.
- Business Quant data shows FATE's EBITDA at -$30.08 million (Q1 2026), -$31.66 million (Q4 2025) and -$31.51 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.34 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Fate Therapeutics | 215.18 Mn | 76.08 Mn | - | -29.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -29.57 Mn |
| Jun 30, 2026 | -28.35 Mn |
| Mar 31, 2026 | -30.08 Mn |
| Dec 31, 2025 | -31.66 Mn |
| Sep 30, 2025 | -31.51 Mn |
| Jun 30, 2025 | -33.69 Mn |
| Mar 31, 2025 | -37.95 Mn |
| Dec 31, 2024 | -56.90 Mn |
| Sep 30, 2024 | -47.77 Mn |
| Jun 30, 2024 | -40.36 Mn |
| Mar 31, 2024 | -46.25 Mn |
| Dec 31, 2023 | -43.17 Mn |
| Sep 30, 2023 | -46.54 Mn |
| Jun 30, 2023 | -58.10 Mn |
| Mar 31, 2023 | -17.21 Mn |
| Dec 31, 2022 | -58.41 Mn |
| Sep 30, 2022 | -82.42 Mn |
| Jun 30, 2022 | -80.48 Mn |
| Mar 31, 2022 | -70.61 Mn |
| Dec 31, 2021 | -65.84 Mn |
API Access
Fate Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=FATE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "FATE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=FATE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();